Human adipose tissue–derived mesenchymal stem cells (AT-MSC) are considered to be a
promising source of autologous stem cells in personalized cell-based therapies. Tumor …

Accumulating laboratory studies have implicated the mobilization of bone marrow (BM)-
derived stem cells in brain plasticity and stroke therapy. This mobilization of bone cells to the …

Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …

Mesenchymal stem cells (MSCs) possess self-renewal and multipotential differentiation
abilities, and they are thought to be one of the most reliable stem cell sources for a variety of …

Adenovirus-mediated gene therapies against brain tumors have been limited by the difficulty
in tracking glioma cells infiltrating the brain parenchyma. Human umbilical cord blood …

Bone marrow mesenchymal stem cells (BMMSCs) are pluripotent cells capable of
differentiating into several cell types and are thus an attractive cell source for connective …

Mesenchymal stem cells (MSCs) play an important role in the development and growth of
tumor cells. The purpose of this study is to confirm the effect of MSCs on tumor cell growth in …

Mesenchymal stem cells (MSCs), which are modulated by cytokines present in the tumor
microenvironment, play an important role in tumor progression. It is well documented that …

Mesenchymal stromal cells (MSCs) possess several fairly unique properties that, when
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …

Recent evidence suggests that mesenchymal stem cells (MSC) selectively proliferate to
tumors and contribute to the formation of tumor-associated stroma. The biological rationale …